Welcome! You are invited to join a webinar: Early-Stage NSCLC: Advances in Diagnosis, Tissue Acquisition, and Treatment. After registering, you will receive a confirmation email about joining the webinar.
This webinar will explore the evolving landscape of diagnosis and treatment for stage I and II non-small cell lung cancer (NSCLC). Participants will gain critical insights into current best practices in tissue acquisition, including the role of high-quality biopsies and biomarker testing strategies. Expert faculty will walk through the latest diagnostic algorithms, highlight key differences in management based on epidermal growth factor receptor and anaplastic lymphoma kinase mutation status, and examine treatment pathways, including surgery, perioperative systemic therapy (including targeted therapy and immunotherapy), and stereotactic body radiation therapy for patients who are inoperable. The session will also address interdisciplinary coordination in early-stage lung cancer care and equip clinicians with up-to-date guidance for integrating molecular profiling into therapeutic decision-making. A live Q&A will follow the presentation to facilitate audience engagement with the faculty
